BFC220
BFC220 is a covalent SARS-CoV-2 Mpro inhibitor with an IC50 of 2.77 μM. BFC220 can be used for antiviral research[1].
Product Specifications
CAS Number
[143-85-1]
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(CCl)N1CCC(C(C2=CC=CC=C2)(C3=CC=CC=C3)O)CC1
Molecular Formula
C20H22ClNO2
Molecular Weight
343.85
References & Citations
[1]Steuten K, et al. Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19. ACS Infect Dis. 2021 Jun 11;7 (6) :1457-1468.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
N0800-04R 200 µL
NEK4, CT (Never in Mitosis A-related Kinase 4, NimA-related Protein Kinase 4, MGC33171, NRK2, pp12301, Serine/threonine Protein Kinase 2, STK2, Serine/threonine Protein Kinase Nek4, Serine/threonine Protein Kinase NRK2)
Ask
View Details 
MBS6279798-01 0.1 mL
C1RL, ID (C1RL, C1RL1, C1RLP, CLSPA, Complement C1r subcomponent-like protein, C1r-like serine protease analog protein) (MaxLight 490)
Ask
View Details MBS6279798-02 5x 0.1 mL
C1RL, ID (C1RL, C1RL1, C1RLP, CLSPA, Complement C1r subcomponent-like protein, C1r-like serine protease analog protein) (MaxLight 490)
Ask
View Details